Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

MORU’s Medicine Quality Research Group (MQRG) organised a multidisciplinary hybrid meeting at Keble College, Oxford, 3-6 July for the Wellcome Collaborative Award-funded FORESFA project (‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’).

FORESFA conference 2022 Oxford group photo

The multidisciplinary hybrid meeting drew 53 colleagues from 12 countries, including pharmacists, forensic geneticists and chemists, modellers, sociologists, data scientists, informaticians, microbiologists, criminologists, public engagement specialists and food safety scientists, with national and international organization representatives. They met for vibrant discussions and planning for FORESFA. Those present in person went for after lunch walks, including to the Sir William Dunn School of Pathology blue plaque commemorating where penicillin was first brewed up to administer to patients (pictured).

On 6-8 July, the indefatigable MQRG held another, overlapping, multidisciplinary hybrid meeting, also at Keble, to discuss the Vaccine Identity Evaluation (VIE) project, which is evaluating devices for screening for substandard and falsified (SF) vaccines in supply chains. The VIE team, of the CTMGH, Department of Biochemistry and Department of Chemistry, Oxford and the Science and Technology Facilities Council’s Rutherford Appleton Laboratory (RAL), were joined by 60 colleagues from 11 countries including vaccine and device manufacturers, medicines regulators, virologists, chemists, physicists, forensic scientists, data scientists, police and investigators, sociologists and translational research experts. Pilot data were discussed and much progress made on future collaborative plans with a vision to bring about a step change in our ability to detect SF vaccines. The diverse devices were demonstrated at RAL and in Biochemistry and Chemistry.

- Paul Newton.

Similar stories

Village drama against malaria project wins University Public Engagement with Research Award

A project using drama that engages with village communities in Cambodia, led by Professor Phaik Yeong Cheah of the Mahidol Oxford Tropical Medicine Research Unit and Nuffield Department of Medicine, has won a Project award in this year’s Vice-Chancellor’s Public Engagement with Research Awards. The project also won the Vice-Chancellor’s Choice Award for Public Engagement with Research.

After MQPH 2018, new collaborations to fight substandard medicines

Over 200 delegates travelled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH 2018) in Oxford from 23-28 Sept. The conference, at Keble College, brought together experts in pharmacy, public health, chemistry, law, sociology, governance and ethics, from medicines regulatory authorities, academia, pharmaceutical industry, NGOs, and international organisations.

Art exhibition on Fake Medicine, the disease of greed

Visit the Radcliffe Science Library before 4th January 2019 to see a new art exhibition of 14 prints illustrating the global health impact of poor quality medicines. The proliferation of poor quality medicines is an important but neglected public health problem, threatening millions of people all over the world, both in developing and wealthy countries.

Fake drugs: the global industry putting your life at risk

The manufacture and distribution of medicines is a global industry, tainted by fake and substandard products. Not only might these drugs not work as expected, but some are even contributing to antimicrobial resistance. So, what’s in your medicine cabinet? This is an article on Mosaic, a Wellcome publication

The Oxford Statement - lets demand medicines we can trust

Every person has the right to expect that when they use a medical product, whether medicine, vaccine or diagnostic kit, it works. But too often, that is not the case. Substandard medical products result from errors, negligence or poor practice in manufacturing, transportation and/or storage. In contrast, falsified products result from criminal fraud. Both innovative and generic products are affected.

Sparking collaborations and discussions on substandard and falsified medicines at MQPH 2018

Over 200 delegates traveled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH) in Oxford from 23-28 September 2018. The conference brought together experts from academia, public health, pharmacy, chemistry, law, ethics, social sciences, public engagement, health policy, with national medicines regulatory authorities, NGOs, international organizations and donors. Conference partners presented the latest evidence on substandard, falsified and unregulated medicines, and discussed strategies to tackle this global challenge.